Location Paris, Ile-de-France, France Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Nicolas joined Coave Therapeutics in 2021 as CDO bringing more than 30 years’ experience in cell and gene therapy and having authored more than 100 scientific publications. Prior to joining Coave Therapeutics, he was Scientific Director of the Department of Cell and Gene Therapy at Servier Laboratories from 2018 to 2020. He was previously
developing a platform for cell and gene therapy at the Saint Louis hospital in Paris. Nicolas also spent more than 25 years as a scientist at INSERM, where he developed new gene and cell therapy strategies for liver cancer and hereditary liver diseases. He set up his own INSERM laboratory in 2009 and was an expert in gene therapy for the French regulatory authority (AFFSAPS) from 2000 to 2010. In 2011, he joined the French Medicines Agency (ANSM) as head of the Department of Vaccines, Blood Products and Advanced Therapies. From 2011 to 2016, Nicolas was also a member of the European Medicines Agency’s Committee for Advanced Therapies. Nicolas was trained as an M.D., Ph.D. from Paris University.
